SMS Pharmaceuticals Share Price

SMS Pharmaceuticals Share Price

NSE: SMSPHARMA
|
Pharmaceuticals
|
S Cap
₹ 483.35
+₹16.85 (3.61%)
1D
Last updated 22 Sep, 2026, 15:59 IST

SMS Pharmaceuticals Share Price Today

As of 23 Sep 2026, SMS Pharmaceuticals share price is ₹483.35. The stock opened at ₹467.85, compared to its previous close of ₹466.50. During today's trading session, SMS Pharmaceuticals share price moved in the range of ₹467.85 to ₹494.45, with an average price of ₹481.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹242.25 and a high of ₹494.45. On the performance front, SMS Pharmaceuticals share price has increased by 25.53% over the last six months and is up 70.55% on a year-on-year basis.

₹467.85
3.61% up today
₹494.45
1D LOW
1D HIGH

SMS Pharmaceuticals Returns Calculator

Circuit
L
H
₹386.70
₹580.00
52-week
L
H
₹242.25
₹494.45

About SMS Pharmaceuticals

SMS Pharmaceuticals Share Price
ISIN
INE812G01025
Sector Market Cap
₹ 4,368.40 Cr

SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.

SMS Pharmaceuticals Financial Highlights

  • Revenue: SMS Pharmaceuticals reported revenue of ₹895.22 crore in FY26 vs ₹788.97 crore in FY25. It showed an increase of 13.47% on a yearly basis.
  • Operating Profit: SMS Pharmaceuticals reported an operating profit of ₹116.64 crore in FY26 vs ₹92.34 crore in FY25. It showed an increase of 26.32% on a year-on-year basis.
  • Net Profit: SMS Pharmaceuticals reported a net profit of ₹88.00 crore in FY26 vs ₹67.40 crore in FY25. It showed an increase of 30.56% on a yearly basis.

SMS Pharmaceuticals Quarterly Result Highlights

  • SMS Pharmaceuticals reported revenue of ₹208.70 crore in Jun 2026, compared with ₹240.52 crore in Mar 2026, representing a decrease of 13.23% on a quarter-on-quarter (QoQ) basis.
  • SMS Pharmaceuticals reported an operating profit of ₹27.21 crore in Jun 2026, compared with ₹27.07 crore in Mar 2026, representing an increase of 0.52% on a quarter-on-quarter (QoQ) basis.
  • SMS Pharmaceuticals reported a profit of ₹20.20 crore in Jun 2026, compared with ₹20.96 crore in Mar 2026, reflecting a decrease of 3.63% on a QoQ basis.
  • The earnings per share (EPS) of SMS Pharmaceuticals stood at ₹8.16 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
68.07%
FII
0.65%
Other DII
0.02%
Retail and other
28.45%
Mutual funds
2.81%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.28%
Dec 20250.04%
Mar 20260.31%
Jun 20260.65%
Mkt Cap Cr
4,368.40
P/E
44.19
P/B
5.76
ROE
12.98%
D/E
0.45
ROCE
12.14%
Div. Yield
0.08%
EPS(TTM)
9.58
Turnover
0.65
EV/EBITDA
25.71
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.57%
Quick Ratio
0.00
Curr. Ratio
4.00
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
SMS Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
SMS Pharma. appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
SMS Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SMS Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹782.75₹709.26₹522.05₹519.87
Other Income₹6.22₹4.46₹4.91₹5.20
Total Revenue₹788.97₹713.72₹526.97₹525.07
Total Expenses₹696.64₹647.62₹521.62₹456.57
Profit Before Tax₹92.34₹66.11₹5.35₹68.50
Tax₹24.94₹16.91₹1.47₹0.62
Profit After Tax₹67.40₹49.20₹3.88₹67.88
EPS - Basic₹8.16₹5.89-₹0.83₹7.35
EPS - Diluted₹8.16₹5.89-₹0.83₹7.35

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹92.34₹66.11₹5.35₹68.50
Income before WC changes₹144.62₹120.07₹58.34₹118.36
Change in Assets-₹13.39-₹106.90-₹72.70-₹60.34
Change in Liabilities-₹29.69₹52.35₹41.41₹1.96
Change in WC-₹43.08-₹54.55-₹31.29-₹58.38
Cash flow from Operations₹81.71₹50.12₹22.45₹45.06
Cash flow from Investing-₹123.43-₹52.07-₹29.76-₹27.15
Cash flow from Financing₹47.08₹30.68-₹31.97-₹11.75
Total Cash Flow₹5.36₹28.73-₹39.28₹6.16
Cash (Start of the year)₹36.04₹7.31₹46.58₹40.42
Cash (End of the year)₹41.40₹36.04₹7.31₹46.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹598.21₹500.20₹468.96₹482.45
Current Assets₹554.47₹533.89₹410.65₹377.05
Total Assets₹1,152.68₹1,034.09₹879.61₹859.50
Current Liabilities₹324.37₹331.72₹254.91₹196.48
Net Current Asset₹230.10₹202.18₹155.74₹180.57
Non-Current Liabilities₹188.67₹166.05₹164.17₹192.73
Equity Capital₹639.64₹536.33₹460.53₹470.29
Total Equity & Liabilities₹1,152.68₹1,034.09₹879.61₹859.50

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹782.75₹709.26₹522.05₹519.87
Other Income₹6.22₹4.46₹4.91₹5.20
Total Revenue₹788.97₹713.72₹526.97₹525.07
Total Expenses₹695.65₹647.39₹521.42₹456.42
Profit Before Tax₹93.32₹66.33₹5.55₹68.65
Tax₹24.94₹16.91₹1.47₹0.62
Profit After Tax₹68.38₹49.42₹4.08₹68.04
EPS - Basic₹8.07₹5.84₹0.48₹8.04
EPS - Diluted₹8.07₹5.84₹0.48₹8.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹93.32₹66.33₹5.55₹68.65
Income before WC changes₹144.63₹120.07₹58.34₹118.36
Change in Assets-₹13.39-₹106.90-₹72.70-₹60.34
Change in Liabilities-₹29.69₹52.35₹41.41₹1.96
Change in WC-₹43.08-₹54.55-₹31.29-₹58.38
Cash flow from Operations₹81.71₹50.12₹22.45₹45.06
Cash flow from Investing-₹123.44-₹52.07-₹29.76-₹27.15
Cash flow from Financing₹47.08₹30.68-₹31.97-₹11.75
Total Cash Flow₹5.35₹28.73-₹39.28₹6.16
Cash (Start of the year)₹36.04₹7.31₹46.58₹40.42
Cash (End of the year)₹41.39₹36.04₹7.31₹46.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹631.64₹534.36₹503.54₹505.92
Current Assets₹554.46₹533.89₹410.65₹377.05
Total Assets₹1,186.10₹1,068.25₹914.18₹882.97
Current Liabilities₹324.36₹331.72₹254.91₹196.48
Net Current Asset₹230.10₹202.18₹155.74₹180.57
Non-Current Liabilities₹188.67₹166.05₹164.17₹192.73
Equity Capital₹673.07₹570.49₹495.10₹493.76
Total Equity & Liabilities₹1,186.10₹1,068.25₹914.18₹882.97
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
483.35
756
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 756
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
71.55
Bullish
ATR (14)
29.86
Neutral
STOCH(9,6)
89.03
Bearish
STOCH RSI (14)
60.43
Neutral
ADX(9)
56.52
Bearish
UO(9)
55.04
Neutral
ROC(12)
29.19
Bullish
WillR(14)
-8.39
Bearish
Period
Simple value
Exponential vaue
5D
441.9
452.93
10D
430.7
433.81
20D
400.86
412.81
50D
384.82
394.37
100D
388.47
387.6
Volume trend — traded volume by day
22 Sep19L
21 Sep22L
18 Sep17L
17 Sep6L
16 Sep8L
Average14L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SMS Pharmaceuticals Share Price
SMS Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

SMS Pharmaceuticals Share Price FAQs

SMS Pharmaceuticals share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837